A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts.

Marras, Connie; Lang, Anthony E; Eberly, Shirley W; Oakes, David; Fahn, Stanley; Schwid, Steven R; Hyson, Christopher; Shoulson, Ira

Marras, Connie; Lang, Anthony E; Eberly, Shirley W; Oakes, David; Fahn, Stanley; Schwid, Steven R; Hyson, Christopher; Shoulson, Ira.

Affiliation

Marras C; Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, Toronto, Ontario, Canada. connie.marras@utoronto.ca

Mov Disord ; 24(16): 2370-8, 2009 Dec 15.

Article in En | MEDLINE | ID: mdl-19908310

Subject(s)

Antioxidants/therapeutic use; Parkinson Disease/drug therapy; Selegiline/therapeutic use; Tocopherols/therapeutic use; Aged; Cohort Studies; Disability Evaluation; Double-Blind Method; Female; Humans; Male; Middle Aged; Retrospective Studies

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Selegiline / Tocopherols / Antioxidants Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2009 Type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google